Bharat Bio gets licence for clot buster drug
Bharat Biotech International Ltd (BBIL) has obtained manufacture and marketing licence for recombinant Streptokinase, the 'clot buster' drug, from the Drug Controller General of India (DGI). Claiming
Bharat Biotech International Ltd (BBIL) has obtained manufacture and marketing licence for recombinant Streptokinase, the 'clot buster' drug, from the Drug Controller General of India (DGI). Claiming